# Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans

> **NCT02789241** · PHASE1 · COMPLETED · sponsor: **Robert J Noveck, M.D.** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Endotoxin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02789241
- **Lead sponsor:** Robert J Noveck, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789241, "Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02789241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*